Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism.
Ahmed Hasbi, Bertha K. Madras, Susan R George
Biological Psychiatry Global Open Science July 2023 DOI: 10.1016/j.bpsgos.2022.07.003 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical rodent study Peer reviewed |
|---|---|
| Population | Male rats |
| Intervention | THC |
| Dose | 1 mg/kg |
| Duration | 9 days of daily THC, 7 days of spontaneous withdrawal |
| Topics | Addiction Anxiety Cannabis Depression |
| Keywords | Anhedonia Bdnf Cb1 Calcium Cannabinoid D1-d2 Dimer Dopamine receptor Dynorphin Gpcr Heteromer Kor Kappa Opioid Trkb Withdrawal |
| Key points | Chronic THC produced anhedonic- and anxiogenic-like behaviors that persisted for at least 7 days after cessation, linked to increased nucleus accumbens D1-D2 receptor heteromer expression, calcium signaling, BDNF/TrkB activation, dynorphin, and kappa opioid receptor signaling. Disrupting the D1-D2 heteromer with an interfering peptide during withdrawal reversed the behaviors and neurochemical changes, suggesting the heteromer drives these negative effects. |
Abstract
Frequent cannabis use is associated with a higher risk of developing cannabis use disorder and other adverse consequences. However, rodent models studying the underlying mechanisms of the reinforcing and withdrawal effects of the primary constituent of cannabis, Δ9-tetrahydrocannabinol (THC), have been limited. This study investigated the effects of daily THC (1 mg/kg, intraperitoneal, 9 days) and spontaneous withdrawal (7 days) on hedonic and aversion-like behaviors in male rats. In parallel, underlying neuroadaptive changes in dopaminergic, opioidergic, and cannabinoid signaling in the nucleus accumbens were evaluated, along with a candidate peptide designed to reverse altered signaling. Chronic THC administration induced anhedonic- and anxiogenic-like behaviors not attributable to altered locomotor activity. These effects persisted after drug cessation. In the nucleus accumbens, THC treatment and withdrawal catalyzed increased cannabinoid CB1 receptor activity without modifying receptor expression. Dopamine D1-D2 receptor heteromer expression rose steeply with THC, accompanied by increased calcium-linked signaling, activation of BDNF/TrkB (brain-derived neurotrophic factor/tropomyosin receptor kinase B) pathway, dynorphin expression, and kappa opioid receptor signaling. Disruption of the D1-D2 heteromer by an interfering peptide during withdrawal reversed the anxiogenic-like and anhedonic-like behaviors as well as the neurochemical changes. Chronic THC increases nucleus accumbens dopamine D1-D2 receptor heteromer expression and function, which results in increased dynorphin expression and kappa opioid receptor activation. These changes plausibly reduce dopamine release to trigger anxiogenic- and anhedonic-like behaviors after daily THC administration that persist for at least 7 days after drug cessation. These findings conceivably provide a therapeutic strategy to alleviate negative symptoms associated with cannabis use and withdrawal.
Comparable studies
Other preclinical and animal studies on cannabis for anxiety, most cited first.
Citations in the library
Cites 9
- Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis Substance Abuse February 22, 2021
- The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review Frontiers in Psychiatry February 16, 2021
- Cannabis and the developing brain challenge risk perception. Journal of Clinical Investigation June 22, 2020
- A Model of Δ9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens. Biological Psychiatry October 15, 2018
- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments. Neuroscience & Biobehavioral Reviews April 2017
and 4 more in the library